I-Mab
ANTI-PD-L1 ANTIBODY AND IL-7 FUSIONS

Last updated:

Abstract:

Provided are fusion molecule having a PD-L1 inhibitor fused to a human IL-7 protein or fragment thereof through a peptide linker. The disclosed fusion molecules exhibited synergistic anti-tumor effects.

Status:
Application
Type:

Utility

Filling date:

25 Jan 2019

Issue date:

21 Nov 2019